About the Journal

Clinical Therapeutics provides peer-reviewed, rapid publication of recent developments in drug therapy and pharmaceutical economics, as well as in-depth supplements on specific drug therapies or disease states. The journal serves an international audience of scientists and clinicians in a variety of research, academic, and clinical practice settings by quickly disseminating research findings. In addition, the articles are indexed by all major biomedical abstracting databases.

Published articles range from studies exploring new drugs and new indications for existing drugs to large, multicenter Phase III and IV trials. In addition to publishing the results of a broad range of multispecialty clinical studies, the journal features 3 specialty sections: Pediatric, Adolescent, & Maternal Therapeutics, which addresses matters regarding safe and effective drug therapy in neonates, infants, children, adolescents, and pregnant or lactating women; Pharmaceutical Economics & Health Policy, which addresses pharmacoeconomic, health outcomes, and contemporary issues related to drug therapy; and Pharmacokinetics, Bioavailability, & Bioequivalence, which features pharmacokinetic studies conducted to assess the bioequivalence of generic and branded pharmaceuticals and/or alternative formulations. The journal also encourages submission of brief reports and commentaries on topics that are timely or provocative.

All manuscripts are peer reviewed by at least 2 independent researchers for clinical relevance, technical accuracy, methodologic rigor, clarity, and objectivity.